Answers are grounded in this paper and cite their sources.
Reports the discovery of new PolQ inhibitors in drug development, suggesting AI enhances the process.
High Resolution Image Download MS PowerPoint Slide Application of generative AI, synergistically with traditional knowledge-based approaches, has expedited the discovery of small-molecule PolQ polymerase domain inhibitors. Leveraging AI-generated ligand designs, a structurally diverse set of compounds were synthesized and evaluated, ultimately identifying a novel oxime-based scaffold as a promising starting point. Although the initial hit demonstrated only modest biochemical potency, the oxime moiety─an unexplored vector in this chemical space─offered an opportunity for strategic substitution. Gratifyingly, using this strategy, a highly potent array of functionalized oxime PolQ inhibitors displaying promising initial ADME properties was delivered, underscoring the power of generative AI to unlock new chemical space and accelerate lead optimization.
No takes yet. Share an insight, caveat, or question.
Miccoli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: